歯科薬物療法
Online ISSN : 1884-4928
Print ISSN : 0288-1012
ISSN-L : 0288-1012
原著
2005年から2015年に分離された歯性感染症由来Streptococcus属に対する第一世代セフェム系薬の抗菌活性
渡辺 大介金子 明寛水澤 伸仁窪田 弘幸中西 康大内堀 正博金坂 伊須萌松崎 薫
著者情報
ジャーナル フリー

2016 年 35 巻 3 号 p. 123-126

詳細
抄録

When oral administration is possible, penicillin agents are recommended for infectious endocarditis in the antibacterial prophylaxis method during dental treatment. If the patient is allergic to penicillin, first-generation cephem agents are recommended. As of 2003, the antibacterial activities of cepfalexin(CEX) and cefaclor(CCL) against oral Streptococci from odontogenic infections were as follows:CEX –MIC90 was > 100μg/mL;CCL– MIC90 was 100μg/mL. We measured the antibacterial activities of CEX, CCL, cefditoren and amoxicillin(AMPC) with respect to the 50 respective shares of the Streptococcus mitis group and the Sterptococcus anginosus group for each fiscal year from 2005 to 2015.

The annual changes of MIC90 value of each agents for S. mitis group were found to be as follows:For CEX, it was 16〜64μg/mL; for CCL, 4〜32μg/mL;for AMPC, 0.12〜0.5μg/mL. The annual changes of the MIC90 value of each agent in the S. anginosus group were found to be as follows:For CEX, it was 8〜16μg/mL;for CCL, 4〜8μg/mL;for AMPC, 0.12〜0.25μg/mL.

著者関連情報
© 2016 日本歯科薬物療法学会
前の記事 次の記事
feedback
Top